| edit |
| Natriuretski peptidni receptor B/guanilat ciklaza B (atrionatriuretski peptidni receptor B) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifikatori | |||||||||||
| Simboli | NPR2; AMDM; ANPRB; ANPb; GUC2B; GUCY2B; NPRB; NPRBi | ||||||||||
| Vanjski ID | OMIM: 108961 MGI: 97372 HomoloGene: 2970 GeneCards: NPR2 Gene | ||||||||||
| EC broj | 4.6.1.2 | ||||||||||
| |||||||||||
| Ortolozi | |||||||||||
| Vrsta | Čovek | Miš | |||||||||
| Entrez | 4882 | 230103 | |||||||||
| Ensembl | ENSG00000159899 | ENSMUSG00000028469 | |||||||||
| UniProt | P20594 | Q6VVW5 | |||||||||
| RefSeq (mRNA) | NM_000907.2 | NM_173788.3 | |||||||||
| RefSeq (protein) | NP_003986.2 | NP_776149.1 | |||||||||
| Lokacija (UCSC) | Chr 9: 35.79 - 35.81 Mb | Chr 4: 43.63 - 43.65 Mb | |||||||||
| PubMed pretraga | [1] | [2] | |||||||||
Natriuretski peptidni receptor B (atrionatriuretski peptidni receptor B, NPR2) je receptor atrijalnog natriuretskog peptida. Ovaj receptor je kod čoveka kodiran NPR1 genom.[1]
- Fox AA, Collard CD, Shernan SK, et al. (2009). „Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.”. Anesthesiology 110 (4): 738–47. DOI:10.1097/ALN.0b013e31819c7496. PMC 2735337. PMID 19326473.
- Potthast R, Abbey-Hosch SE, Antos LK, et al. (2004). „Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B.”. J. Biol. Chem. 279 (47): 48513–9. DOI:10.1074/jbc.M408247200. PMID 15371450.
- Liew D, Schneider H, D'Agostino J, et al. (2004). „Utility of B-type natriuretic peptide as a screen for left ventricular dysfunction in patients with diabetes: response to Epshteyn et al.”. Diabetes Care 27 (3): 848; author reply 848–9. DOI:10.2337/diacare.27.3.848. PMID 14988324.
- Antos LK, Abbey-Hosch SE, Flora DR, Potter LR (2005). „ATP-independent activation of natriuretic peptide receptors.”. J. Biol. Chem. 280 (29): 26928–32. DOI:10.1074/jbc.M505648200. PMID 15911610.
- Poreba R, Poczatek K, Gać P, et al. (2009). „SNP rs198389 (T-381 C) polymorphism in the B-type natriuretic peptide gene promoter in patients with atherosclerotic renovascular hypertension.”. Pol. Arch. Med. Wewn. 119 (4): 219–24. PMID 19413180.
- Koller KJ, Goeddel DV (1992). „Molecular biology of the natriuretic peptides and their receptors.”. Circulation 86 (4): 1081–8. PMID 1327579.
- Fan D, Bryan PM, Antos LK, et al. (2005). „Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize.”. Mol. Pharmacol. 67 (1): 174–83. DOI:10.1124/mol.104.002436. PMID 15459247.
- Pagel-Langenickel I, Buttgereit J, Bader M, Langenickel TH (2007). „Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.”. J. Mol. Med. 85 (8): 797–810. DOI:10.1007/s00109-007-0183-4. PMID 17429599.
- Rahmutula D, Cui J, Chen S, Gardner DG (2004). „Transcriptional regulation of type B human natriuretic Peptide receptor gene promoter: dependence on Sp1.”. Hypertension 44 (3): 283–8. DOI:10.1161/01.HYP.0000136908.60317.92. PMID 15262909.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). „DNA sequence and analysis of human chromosome 9.”. Nature 429 (6990): 369–74. DOI:10.1038/nature02465. PMC 2734081. PMID 15164053.
- Hume AN, Buttgereit J, Al-Awadhi AM, et al. (2009). „Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux.”. Hum. Mol. Genet. 18 (2): 267–77. DOI:10.1093/hmg/ddn354. PMC 2638773. PMID 18945719.
- Schulz S (2005). „C-type natriuretic peptide and guanylyl cyclase B receptor.”. Peptides 26 (6): 1024–34. DOI:10.1016/j.peptides.2004.08.027. PMID 15911070.
- Tsuji T, Kunieda T (2005). „A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.”. J. Biol. Chem. 280 (14): 14288–92. DOI:10.1074/jbc.C500024200. PMID 15722353.
- Dickey DM, Yoder AR, Potter LR (2009). „A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation.”. J. Biol. Chem. 284 (29): 19196–202. DOI:10.1074/jbc.M109.010777. PMC 2740543. PMID 19458086.
- Nozohoor S, Nilsson J, Lührs C, et al. (2009). „B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.”. J. Cardiothorac. Vasc. Anesth. 23 (2): 161–5. DOI:10.1053/j.jvca.2008.11.006. PMID 19167912.
- Hachiya R, Ohashi Y, Kamei Y, et al. (2007). „Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.”. J. Clin. Endocrinol. Metab. 92 (10): 4009–14. DOI:10.1210/jc.2007-1101. PMID 17652215.
- Gratacòs M, Costas J, de Cid R, et al. (2009). „Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.”. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (6): 808–16. DOI:10.1002/ajmg.b.30902. PMID 19086053.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). „The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”. Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Bartels CF, Bükülmez H, Padayatti P, et al. (2004). „Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.”. Am. J. Hum. Genet. 75 (1): 27–34. DOI:10.1086/422013. PMC 1182004. PMID 15146390.
- van den Akker F (2001). „Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors.”. J. Mol. Biol. 311 (5): 923–37. DOI:10.1006/jmbi.2001.4922. PMID 11556325.